STRM.BIO Secures $8 Million in Series Seed 2 Financing for Non-Viral Delivery Technologies

Biotech company STRM.BIO secures $8 million in Series Seed 2 financing from Recordati and existing investors with the round set to close by Q1 2026.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here